Churchill Capital XIV, a blank check company founded by dealmaker and former Citi executive Michael Klein, has filed with the Securities and Exchange Commission to raise up to $300 million in an initial public offering. The New York-based SPAC plans to offer 30 million units at $10 each, with a focus on businesses that demonstrate recurring revenue, stable free cash flow potential, and opportunities for growth through acquisitions.
IPO Structure and Terms
Churchill Capital XIV intends to raise $300 million by offering 30 million units at $10 per unit. Each unit consists of one share of common stock and one-tenth of one warrant. Each whole warrant will be exercisable to purchase one share at $11.50.
The company plans to list on the Nasdaq under the symbol CXIVU. Citi has been appointed as the sole bookrunner for the offering.
Leadership and Investment Strategy
Churchill Capital XIV is led by CEO and Chairman Michael Klein, founder and Managing Partner of strategic advisory firm M. Klein and Company. Klein previously held various positions at Citi and Salomon Smith Barney and has extensive experience sponsoring special purpose acquisition companies.
He is joined by CFO Jay Taragin, who also serves as CFO of M. Klein and Company.
The SPAC has not identified a specific target industry. Instead, it intends to pursue businesses with recurring revenue, the potential to generate stable free cash flow, and opportunities to expand through additional acquisitions. Other stated selection criteria include opportunities sourced through Churchill’s proprietary channels and companies with committed and capable management teams.
Churchill Capital’s SPAC Track Record
Klein has sponsored multiple SPACs across different sectors, including technology, healthcare, electric vehicles, and advanced computing.
His more recent vehicles include Churchill Capital XIII, which went public in July 2026, and Churchill Capital XII, which listed in April 2026. Churchill Capital XI, which went public in December 2025, is expected to complete its merger with humanoid robotics developer Agility Robotics this week.
Churchill Capital X previously merged with quantum computing developer Infleqtion in February 2026. Churchill Capital Corp IX, meanwhile, terminated its proposed merger with autonomous driving technology company PlusAI in April 2026.
Earlier transactions include Churchill Capital Corp IV, which merged with electric vehicle manufacturer Lucid in 2021, and Churchill Capital Corp III, which merged with healthcare services provider MultiPlan, now known as Claritev, in 2020. Klein also sponsored AltC Acquisition, which merged with small modular reactor developer Oklo in 2024.
Other vehicles, including Churchill Capital Corp VII, Churchill Capital VI, and Churchill Capital V, ultimately liquidated.
Market Context and Opportunities
Churchill Capital XIV enters the IPO pipeline with a broad investment mandate rather than a predefined sector focus. Its stated preference for recurring revenue, free cash flow potential, and acquisition-led expansion suggests an emphasis on established businesses with identifiable operating characteristics.
The sponsor’s previous transactions span several industries, providing a track record of pursuing opportunities across different market environments. However, the new SPAC has not disclosed a specific acquisition target, and its eventual investment direction will depend on the opportunities identified through its sourcing network.
Risks and Challenges
As with other SPACs, Churchill Capital XIV must identify and complete a suitable business combination following its public listing. Its broad mandate provides flexibility but leaves investors without a defined target industry or acquisition candidate at the filing stage.
The sponsor’s previous SPAC outcomes have also varied, including completed mergers, terminated transactions, and liquidations. These different outcomes highlight the importance of evaluating the eventual target, transaction valuation, and proposed business combination rather than relying solely on the sponsor’s experience.
Closing Insights
Churchill Capital XIV’s proposed $300 million IPO adds another investment vehicle to Michael Klein’s extensive SPAC portfolio. Its focus on recurring revenue, free cash flow potential, and acquisition opportunities provides an initial framework for its investment strategy, although no target company or sector has been identified. Investors will be watching the offering process and subsequent acquisition search to determine how the new SPAC translates its broad mandate into a transaction.
